Innate immune pattern-recognition receptors sensing Modified Vaccinia Ankara components (PRRs)

Innate immune pattern-recognition receptors (PRRs) sensing Modified Vaccinia Ankara (MVA) components are a collective group of germline-encoded sensors that detect viral molecular patterns to initiate host defense. MVA, a highly attenuated poxvirus used extensively as a vaccine vector, is primarily recognized by the cyclic GMP-AMP synthase (cGAS), which detects viral double-stranded DNA in the cytoplasm and signals through the stimulator of interferon genes (STING) pathway (Dai et al., 2014, PLoS Pathogens). This recognition is the dominant driver of Type I interferon production in dendritic cells and macrophages. Additionally, Toll-like receptor 2 (TLR2) senses viral surface proteins, while melanoma differentiation-associated protein 5 (MDA5) and the NLRP3 inflammasome contribute to the detection of viral RNA and the production of pro-inflammatory cytokines like IL-1β (Delaloye et al., 2009, PLoS Pathogens). These receptors are critical for the immunogenicity of MVA-based vaccines, as they provide the necessary danger signals to prime robust adaptive T-cell and B-cell responses. Pharmacological modulation of these PRRs, such as through the use of STING or TLR agonists, is a major area of research for enhancing vaccine efficacy and developing novel cancer immunotherapies (Liu et al., 2019, Immunity).

Other names

MVA-sensing PRRsInnate immune sensors of MVAPoxvirus-sensing pattern recognition receptors

Activation of multiple innate immune signaling pathways, including the cGAS-STING, TLR2-MyD88, and MDA5-MAVS pathways, which leads to the induction of Type I interferons and pro-inflammatory cytokines.